Anyone could have written that general and specifics deficient post.
Provide examples of when unrealistic expectations were set. Discuss, in parallel, what was happening with Elite's finances in relation to the macroenvironment. Let's focus on post-Sox CRL, when the company needed to sell existing assets to fund its existence (remember, those opioids that still have not been commercialized by Nostrum, which is focusing on blood diseases); y'a know, back in the days when the challenge was to keep the lights on. Then pivot the explanation to THE pivot to CNS drugs and the subsequent development that was good but had setbacks due to Covid, as has everyone. Then, drop a line or two into the narrative that speaks to how Elite planned well enough to have API on hand to continue manufacturing rather than struggling with a supply chain that has crippled even big companies, as most API comes from China and India. Finally, toss in a few comments on the strategic thinking that was obvious when investors were surprised with a partnership with Dexcel that portends ex-US distribution (an important facet in this is that NO business tells anyone about such strategic decisions until executed; kind of like the recent loan and buying of the property that was a strategic and financial tour de force). Then, what about an IR perspective and a final word on how investors do not fully grasp the importance of the safe harbor statement and the explanation of how it managed to remain open through the pandemic, a not unimportant matter that could have seen a devastating impact if forced to close; as that would have led to an FDA factory audit before being able to reopen. No small issue, as their retained earnings were not that robust to survive closure for any length of time. Now, I am done...
How is that for starters?
News 
Market Data 
Discover 
